You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API losartan potassium and hydrochlorothiazide tablets

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing losartan potassium and hydrochlorothiazide tablets

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206	CELLULOSE, MICROCRYSTALLINE
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206	CROSCARMELLOSE SODIUM
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206	HYDROXYPROPYL CELLULOSE
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206	MAGNESIUM STEARATE
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206	SILICON DIOXIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for losartan potassium and hydrochlorothiazide tablets

Excipient focus: CELLULOSE, MICROCRYSTALLINE

losartan potassium and hydrochlorothiazide tablets drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

losartan potassium and hydrochlorothiazide tablets drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

losartan potassium and hydrochlorothiazide tablets drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

losartan potassium and hydrochlorothiazide tablets drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

losartan potassium and hydrochlorothiazide tablets drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STEARIC ACID

losartan potassium and hydrochlorothiazide tablets drug variants containing STEARIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing STEARIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

losartan potassium and hydrochlorothiazide tablets drug variants containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

losartan potassium and hydrochlorothiazide tablets drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sandoz Inc	losartan potassium and hydrochlorothiazide tablets	0781-5206
PD-Rx Pharmaceuticals Inc	losartan potassium and hydrochlorothiazide tablets	43063-491
>Company	>Ingredient	>NDC

losartan potassium and hydrochlorothiazide tablets drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.